FOXO4-DRI
Senolytic peptide for senescent cell clearance and longevity. Disrupts FOXO4-p53 interaction, selectively inducing apoptosis in senescent cells while sparing healthy cells in aging research.
FOXO4-DRI is a targeted anti-aging peptide that selectively induces senescent cell apoptosis (senolysis) by specifically blocking the interaction between FOXO4 protein and p53 protein, thereby eliminating accumulated senescent cell populations without damaging healthy cells. As a core active raw material in the emerging longevity medicine field, FOXO4-DRI demonstrates unique research value in cellular rejuvenation intervention, tissue functional recovery, and age-related disease adjunct management. It is a cutting-edge peptide raw material actively sought after in the premium anti-aging market and functional medicine sector.
| Parameter | Specification |
| CAS | 2460055-10-9 |
| Molecular Formula | C₅₀H₇₅N₁₅O₁₁ |
| Molecular Weight | 1066.23 g/mol |
| Category | Longevity |
| Purity | ≥99% |
| Status | Research-grade, analytical verified |
| Applications | Senolytic therapy, aging reversal, cellular rejuvenation, longevity |
| CAS | 2460055-10-9 |
|---|---|
| Applications |
Related products
-
-
Thymosin beta 4
CAS: 77591-33-4Applications: Immune modulation, Sports Injury Recovery, Tissue Regeneration, Wound Healing -
L-Carnosine
CAS: 305-84-0Applications: Anti-glycation Research, Antioxidant Studies, Cellular Protection, Detoxification -
Semax
CAS: 80714-61-0Applications: BDNF modulation, Cognitive research, Neuroprotection studies, Stroke recovery